Found: 12
Select item for more details and to access through your institution.
A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy.
- Published in:
- Breast Cancer Research & Treatment, 2008, v. 110, n. 2, p. 327, doi. 10.1007/s10549-007-9726-1
- By:
- Publication type:
- Article
Exposure–response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 2, p. 151, doi. 10.1007/s00280-021-04381-4
- By:
- Publication type:
- Article
Erdafitinib's effect on serum phosphate justifies its pharmacodynamically guided dosing in patients with cancer.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 5, p. 569, doi. 10.1002/psp4.12727
- By:
- Publication type:
- Article
Abiraterone acetate for metastatic castration-resistant prostate cancer after docetaxel failure: A randomized, double-blind, placebo-controlled phase 3 bridging study.
- Published in:
- International Journal of Urology, 2016, v. 23, n. 5, p. 404, doi. 10.1111/iju.13051
- By:
- Publication type:
- Article
Population pharmacokinetics of tipifarnib in healthy subjects and adult cancer patients.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 62, n. 1, p. 81, doi. 10.1111/j.1365-2125.2006.02615.x
- By:
- Publication type:
- Article
Pharmacokinetics of Tipifarnib After Oral and Intravenous Administration in Subjects With Advanced Cancer.
- Published in:
- Journal of Clinical Pharmacology, 2006, v. 46, n. 10, p. 1116, doi. 10.1177/0091270006291034
- By:
- Publication type:
- Article
Author's Reply to Srinivas: "Modeling the Relationship Between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer".
- Published in:
- 2017
- By:
- Publication type:
- Letter
Modeling the Relationship Between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Adjusting Overall Survival Estimates for Treatment Switching in Metastatic, Castration-Sensitive Prostate Cancer: Results from the LATITUDE Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Niraparib with Abiraterone Acetate and Prednisone for Metastatic Castration-Resistant Prostate Cancer: Phase II QUEST Study Results.
- Published in:
- Oncologist, 2023, v. 28, n. 5, p. e309, doi. 10.1093/oncolo/oyad008
- By:
- Publication type:
- Article
In vitro Effects of the Farnesyltransferase Inhibitor Tipifarnib on Myelodysplastic Syndrome Progenitors.
- Published in:
- Acta Haematologica, 2008, v. 120, n. 1, p. 51, doi. 10.1159/000158577
- By:
- Publication type:
- Article
Converging or Crossing Curves: Untie the Gordian Knot or Cut it? Appropriate Statistics for Non-Proportional Hazards in Decitabine DACO-016 Study (AML).
- Published in:
- 2015
- By:
- Publication type:
- journal article